Royalty Pharma plc
US ˙ NasdaqGS ˙ GB00BMVP7Y09

SecurityRPRX / Royalty Pharma plc
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership101,374 shares
Latest Disclosed Value $ 3,333,177
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.50% increase in ownership of RPRX / Royalty Pharma plc

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 101,374 shares of Royalty Pharma plc (US:RPRX) valued at $3,333,177 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 100,874 shares of Royalty Pharma plc. This represents a change in shares of 0.50% during the quarter. The current value of the position is $5,663,765 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 101,374 500 0.50 3,333 -1.77 0.0441
2025-04-25 2025-02-28 NP ROYALTY PHARMA EC GB00BMVP7Y09 100,874 -3,708 -3.55 3,393 21.70 0.0457
2025-01-27 2024-11-30 NP ROYALTY PHARMA EC GB00BMVP7Y09 104,582 742 0.71 2,788 -7.50 0.0378
2024-10-29 2024-08-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 103,840 1,007 0.98 3,014 6.96 0.0447
2024-07-26 2024-05-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 102,833 1,325 1.31 2,819 -8.48 0.0447
2024-04-24 2024-02-29 NP ROYALTY PHARMA EC GB00BMVP7Y09 101,508 1,643 1.65 3,080 13.91 0.0514
2024-01-24 2023-11-30 NP ROYALTY PHARMA EC GB00BMVP7Y09 99,865 159 0.16 2,703 -9.08 0.0518
2023-10-27 2023-08-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 99,706 1,590 1.62 2,973 -7.44 0.0581
2023-07-26 2023-05-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 98,116 318 0.33 3,212 -8.39 0.0693
2023-04-27 2023-02-28 NP ROYALTY PHARMA EC GB00BMVP7Y09 97,798 2,385 2.50 3,506 -16.42 0.0857
2023-01-26 2022-11-30 NP ROYALTY PHARMA EC GB00BMVP7Y09 95,413 2,491 2.68 4,195 7.98 0.1049
2022-10-26 2022-08-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 92,922 9,079 10.83 3,885 12.64 0.0972
2022-07-29 2022-05-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 83,843 2,600 3.20 3,449 8.15 0.0879
2022-04-28 2022-02-28 NP ROYALTY PHARMA EC GB00BMVP7Y09 81,243 1,300 1.63 3,190 0.31 0.0739
2022-01-25 2021-11-30 NP ROYALTY PHARMA EC GB00BMVP7Y09 79,943 2,150 2.76 3,179 5.76 0.0664
2021-10-26 2021-08-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 77,793 1,650 2.17 3,007 -1.57 0.0659
2021-07-22 2021-05-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 76,143 288 0.38 3,055 -13.53 0.0759
2021-04-23 2021-02-28 NP ROYALTY PHARMA EC GB00BMVP7Y09 75,855 -21,576 -22.14 3,533 -14.89 0.0920
2021-01-20 2020-11-30 NP ROYALTY PHARMA EC GB00BMVP7Y09 97,431 31,673 48.17 4,151 52.52 0.1240
2020-10-16 2020-08-31 NP ROYALTY PHARMA EC GB00BMVP7Y09 65,758 65,758 2,721 0.0840
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.